EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Depressed glutamate transporter 1 expression in a mouse model of Dravet syndrome

Mustafa Q Hameed iD, Benjamin Hui, Rui Lin, Paul C MacMullin, Andres Pascual-Leone, Sheryl Anne D Vermudez iD, Alexander Rotenberg iD

Annals of Clinical and Translational Neurology · 2023

DOI: 10.1002/acn3.51851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2023. Verfasst von Mustafa Q Hameed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Neuromodulation Program, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Epilepsies, Myoclonic, Epilepsy, Excitatory Amino Acid Transporter 2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dravet syndrome (DS) is a monogenic, often refractory, epilepsy resultant from SCN1A haploinsufficiency in humans. A novel therapeutic target in DS that can be engaged in isolation or as adjunctive therapy is highly desirable. Here, we demonstrate reduced expression of the rodent glutamate transporter type 1 (GLT‐1) in a DS mouse model, and in wild type mouse strains where Scn1a haploinsufficiency is most likely to cause epilepsy, indicating that GLT‐1 depression may play a role in DS seizures. As GLT‐1 can be upregulated by common and safe FDA‐approved medications, this strategy may be an attractive, viable, and novel avenue for DS treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsies, MyoclonicEpilepsyExcitatory Amino Acid Transporter 2AnimalsHumansMiceAmino Acid Transport System X-AGNAV1.1 Voltage-Gated Sodium ChannelSeizures

Substanzen

Amino Acid Transport System X-AGNAV1.1 Voltage-Gated Sodium ChannelScn1a protein, mouseExcitatory Amino Acid Transporter 2

Autor:innen und Institutionen

  • Neuromodulation Program, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • FM Kirby Neurobiology Center, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Mustafa Q Hameed, Sheryl Anne D Vermudez, Alexander Rotenberg

Förderung

  • NICHD NIH HHS
  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Hameed, M. Q., Hui, B., Lin, R., MacMullin, P. C., Pascual-Leone, A., Vermudez, S. A. D., & Rotenberg, A. (2023). Depressed glutamate transporter 1 expression in a mouse model of Dravet syndrome. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.51851

Vancouver

Hameed MQ, Hui B, Lin R, MacMullin PC, Pascual-Leone A, Vermudez SAD, et al. Depressed glutamate transporter 1 expression in a mouse model of Dravet syndrome. Annals of Clinical and Translational Neurology. 2023. doi:10.1002/acn3.51851

BibTeX
@article{Hameed2023,
  author = {Hameed, Mustafa Q and Hui, Benjamin and Lin, Rui and MacMullin, Paul C and Pascual-Leone, Andres and Vermudez, Sheryl Anne D and Rotenberg, Alexander},
  title = {Depressed glutamate transporter 1 expression in a mouse model of Dravet syndrome},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2023},
  doi = {10.1002/acn3.51851}
}
Kostenlos starten →